rs2269001

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000238.4(KCNH2):​c.1129-1875C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.271 in 152,074 control chromosomes in the GnomAD database, including 6,218 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.27 ( 6218 hom., cov: 33)

Consequence

KCNH2
NM_000238.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.172

Publications

6 publications found
Variant links:
Genes affected
KCNH2 (HGNC:6251): (potassium voltage-gated channel subfamily H member 2) This gene encodes a component of a voltage-activated potassium channel found in cardiac muscle, nerve cells, and microglia. Four copies of this protein interact with one copy of the KCNE2 protein to form a functional potassium channel. Mutations in this gene can cause long QT syndrome type 2 (LQT2). Transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, May 2022]
KCNH2 Gene-Disease associations (from GenCC):
  • long QT syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • long QT syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • short QT syndrome type 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: MODERATE, NO_KNOWN Submitted by: ClinGen, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.629 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000238.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNH2
NM_000238.4
MANE Select
c.1129-1875C>T
intron
N/ANP_000229.1A0A090N8Q0
KCNH2
NM_001406753.1
c.841-1875C>T
intron
N/ANP_001393682.1Q12809-7
KCNH2
NM_172056.3
c.1129-1875C>T
intron
N/ANP_742053.1Q12809-5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNH2
ENST00000262186.10
TSL:1 MANE Select
c.1129-1875C>T
intron
N/AENSP00000262186.5Q12809-1
KCNH2
ENST00000330883.9
TSL:1
c.108+668C>T
intron
N/AENSP00000328531.4Q12809-2
KCNH2
ENST00000461280.2
TSL:1
n.426+668C>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.271
AC:
41135
AN:
151956
Hom.:
6200
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.281
Gnomad AMI
AF:
0.271
Gnomad AMR
AF:
0.332
Gnomad ASJ
AF:
0.301
Gnomad EAS
AF:
0.647
Gnomad SAS
AF:
0.311
Gnomad FIN
AF:
0.315
Gnomad MID
AF:
0.259
Gnomad NFE
AF:
0.211
Gnomad OTH
AF:
0.264
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.271
AC:
41187
AN:
152074
Hom.:
6218
Cov.:
33
AF XY:
0.279
AC XY:
20725
AN XY:
74318
show subpopulations
African (AFR)
AF:
0.281
AC:
11669
AN:
41482
American (AMR)
AF:
0.333
AC:
5090
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.301
AC:
1043
AN:
3466
East Asian (EAS)
AF:
0.647
AC:
3341
AN:
5164
South Asian (SAS)
AF:
0.312
AC:
1507
AN:
4824
European-Finnish (FIN)
AF:
0.315
AC:
3332
AN:
10580
Middle Eastern (MID)
AF:
0.255
AC:
75
AN:
294
European-Non Finnish (NFE)
AF:
0.211
AC:
14310
AN:
67956
Other (OTH)
AF:
0.271
AC:
573
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1491
2982
4472
5963
7454
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
420
840
1260
1680
2100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.239
Hom.:
650
Bravo
AF:
0.278
Asia WGS
AF:
0.450
AC:
1565
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
3.2
DANN
Benign
0.56
PhyloP100
-0.17
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2269001; hg19: chr7-150651816; API